New drug aims to ease social struggles in autism

NCT ID NCT05081245

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested an experimental drug called ML-004 in 168 adolescents and adults with autism spectrum disorder to see if it could improve social communication skills. Participants were randomly assigned to receive either the drug or a placebo for several weeks. The main goal was to measure changes in social communication using a caregiver questionnaire.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder Communication

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APG Research, LLC

    Orlando, Florida, 32803, United States

  • Abba Medical Group

    Miami, Florida, 33176, United States

  • BioBehavioral Research of Austin

    Austin, Texas, 78759, United States

  • Brain and Mind Centre

    Camperdown, New South Wales, 2050, Australia

  • Cedar Clinical Research

    Draper, Utah, 84020, United States

  • Center for Autism and the Developing Brain, New York State Psychiatric Institute

    White Plains, New York, 10605, United States

  • Children's National Health System - The Children's Research Institute (CRI)

    Washington D.C., District of Columbia, 20010, United States

  • Cortica

    San Rafael, California, 94903, United States

  • Cortica Healthcare

    Glendale, California, 91203, United States

  • Family Psychiatry of The Woodlands

    The Woodlands, Texas, 77381, United States

  • Harmonex Neuroscience Research

    Dothan, Alabama, 36303, United States

  • Holland Bloorview Kids Rehabilitation Hospital

    Toronto, Ontario, M4G 1R8, Canada

  • Jersey Shore University Medical Center

    Neptune City, New Jersey, 07753, United States

  • Lawson Health Research Institute/ London Health Sciences Centre

    London, Ontario, N6A 5W9, Canada

  • NRC Research Institute

    Orange, California, 92868, United States

  • Nathan Kline Institute for Psychiatric Research

    Orangeburg, New York, 10962, United States

  • Neurobehavioral Medicine Group

    Bloomfield Hills, Michigan, 48302, United States

  • OCT Research ULC (dba Okanagan Clinical Trials)

    Kelowna, British Columbia, V1Y 1Z9, Canada

  • Ohio State University Nisonger Center

    Columbus, Ohio, 43210, United States

  • Red Oak Psychiatry Associates, PA

    Houston, Texas, 77090, United States

  • Richmond Behavioral Associates

    Staten Island, New York, 10314, United States

  • Road Runner Research, Ltd.

    San Antonio, Texas, 78249, United States

  • Southwest Autism Research & Resource Center, Clinical Research

    Phoenix, Arizona, 85006, United States

  • Suburban Research Associates

    Media, Pennsylvania, 19063, United States

  • The Royal Children's Hospital, Murdoch Children's Research Institute

    Parkville, Victoria, 3052, Australia

  • University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders

    Columbia, Missouri, 65211, United States

  • University of South Florida Psychiatry and Behavioral Neurosciences

    Tampa, Florida, 33613, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23220, United States

  • Yale Child Study Center

    New Haven, Connecticut, 06519, United States